Cefepime Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Cefepime Hydrochloride Injection (injection) from Fresenius Kabi USA, LLC with status To Be Discontinued. The shortage was first posted on 02/10/2026.
Shortage Details
- Status
- To Be Discontinued
- Company
- Fresenius Kabi USA, LLC
- Package NDC
- 63323-326-20
- Dosage Form
- Injection
- Presentation
- Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)
- Initial Posting
- 02/10/2026
- Revised Date